HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough cancers: immunotherapy combo under study
Disease control OngoingThis study is testing two immunotherapy drugs, durvalumab and tremelimumab, in children and teens up to age 17 with advanced solid tumors or certain blood cancers that have not responded to standard treatments. The first part finds the safest dose, and the second part checks if t…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Simple breathing trick may ease chemo side effects
Symptom relief OngoingThis study looked at whether relaxation breathing exercises can reduce nausea and vomiting caused by chemotherapy in people with blood cancers. Sixty-eight patients took part; half did breathing exercises three times a day plus standard care, while the other half received only st…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Marmara University • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC
-
CAR-T immune recovery study withdrawn before enrollment
Knowledge-focused TerminatedThis study was designed to track how the immune system recovers after CAR-T cell therapy and to test a pneumococcal vaccine given six months later. It planned to enroll 50 adults with blood cancers or solid tumors. However, the study was withdrawn before any participants were enr…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC